Earnings Summary

Enfusion Inc’s revenue jumped 14.73% since last year same period to $46.49Mn in the Q4 2023. On a quarterly growth basis, Enfusion Inc has generated 4.8% jump in its revenue since last 3-months.

Enfusion Inc’s net profit fell -20.94% since last year same period to $0.62Mn in the Q4 2023. On a quarterly growth basis, Enfusion Inc has generated -65.92% fall in its net profits since last 3-months.

Enfusion Inc’s net profit margin fell -31.09% since last year same period to 1.34% in the Q4 2023. On a quarterly growth basis, Enfusion Inc has generated -67.48% fall in its net profit margins since last 3-months.

Enfusion Inc’s price-to-earnings ratio after this Q4 2023 earnings stands at 130.86.

Enfusion Inc’s earning per share (EPS) estimates for the current quarter stand at 0.04 - a -20% fall from last quarter’s estimates.

Enfusion Inc’s earning per share (EPS) estimates for the current year stand at 0.04.

Enfusion Inc’s earning per share (EPS) jumped 0% since last year same period to 0.04 in the Q4 2023. This indicates that the Enfusion Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Enfusion Inc’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Enfusion Inc’s return on equity (ROE) stands at 0.1.